As for the receptor of mitophagy, recent studies have shown that the increased level of BNIP3 is related to the poor survival rate of melanoma patients, while the consumption of BNIP3 in B16-F10 melanoma cells will damage the growth of tumors in vivo94. Here, BNIP3 is linked to melanoma.